Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Cervical Neoplasms | 3 | 2015 | 277 | 1.100 |
Why?
|
| Cervix Uteri | 2 | 2013 | 42 | 0.880 |
Why?
|
| Guideline Adherence | 1 | 2015 | 84 | 0.510 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 191 | 0.490 |
Why?
|
| Alphapapillomavirus | 1 | 2013 | 38 | 0.450 |
Why?
|
| DNA, Viral | 2 | 2013 | 304 | 0.430 |
Why?
|
| Vaginal Smears | 1 | 2013 | 57 | 0.430 |
Why?
|
| Papillomavirus Infections | 2 | 2013 | 336 | 0.400 |
Why?
|
| Mass Screening | 1 | 2015 | 462 | 0.390 |
Why?
|
| Cesarean Section | 4 | 2016 | 55 | 0.380 |
Why?
|
| Choriocarcinoma | 1 | 2009 | 2 | 0.350 |
Why?
|
| Puerperal Disorders | 1 | 2009 | 6 | 0.350 |
Why?
|
| Scalp | 1 | 2009 | 12 | 0.350 |
Why?
|
| Fingers | 1 | 2009 | 20 | 0.340 |
Why?
|
| Uterine Neoplasms | 1 | 2009 | 39 | 0.320 |
Why?
|
| Head and Neck Neoplasms | 1 | 2009 | 78 | 0.320 |
Why?
|
| Cholelithiasis | 1 | 2007 | 4 | 0.310 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2007 | 7 | 0.300 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2007 | 7 | 0.300 |
Why?
|
| Skin Neoplasms | 1 | 2009 | 159 | 0.300 |
Why?
|
| Puerto Rico | 6 | 2015 | 1378 | 0.260 |
Why?
|
| Skin | 2 | 2016 | 174 | 0.250 |
Why?
|
| Young Adult | 6 | 2015 | 4268 | 0.240 |
Why?
|
| Early Detection of Cancer | 2 | 2015 | 336 | 0.190 |
Why?
|
| Retrospective Studies | 4 | 2015 | 2026 | 0.170 |
Why?
|
| Female | 10 | 2016 | 20969 | 0.170 |
Why?
|
| Vagina | 2 | 2016 | 81 | 0.160 |
Why?
|
| Hospitals, University | 2 | 2015 | 38 | 0.160 |
Why?
|
| Infant, Newborn | 4 | 2016 | 894 | 0.140 |
Why?
|
| Pregnancy | 5 | 2016 | 1549 | 0.140 |
Why?
|
| Operating Rooms | 1 | 2015 | 4 | 0.140 |
Why?
|
| Mouth | 1 | 2016 | 45 | 0.130 |
Why?
|
| Medical Records | 1 | 2015 | 41 | 0.130 |
Why?
|
| Humans | 10 | 2016 | 37093 | 0.130 |
Why?
|
| Placenta Diseases | 1 | 2014 | 5 | 0.120 |
Why?
|
| DNA Probes, HPV | 1 | 2013 | 3 | 0.120 |
Why?
|
| Hysterectomy | 1 | 2014 | 28 | 0.120 |
Why?
|
| Self Administration | 1 | 2013 | 42 | 0.110 |
Why?
|
| Biopsy | 1 | 2013 | 164 | 0.110 |
Why?
|
| Specimen Handling | 1 | 2013 | 56 | 0.110 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2013 | 39 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 974 | 0.110 |
Why?
|
| Bacteria | 1 | 2015 | 255 | 0.110 |
Why?
|
| Ambulatory Care | 1 | 2013 | 75 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 2014 | 210 | 0.100 |
Why?
|
| Papillomaviridae | 1 | 2013 | 127 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 562 | 0.100 |
Why?
|
| Premature Birth | 1 | 2013 | 75 | 0.100 |
Why?
|
| Adult | 4 | 2014 | 11712 | 0.090 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2009 | 4 | 0.090 |
Why?
|
| Mediastinal Neoplasms | 1 | 2009 | 6 | 0.090 |
Why?
|
| Fetal Death | 1 | 2009 | 18 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2009 | 40 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2009 | 111 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 2721 | 0.070 |
Why?
|
| Adolescent | 2 | 2013 | 5363 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 358 | 0.060 |
Why?
|
| Hospitalization | 1 | 2007 | 388 | 0.060 |
Why?
|
| Middle Aged | 1 | 2013 | 10129 | 0.040 |
Why?
|
| Child | 1 | 2007 | 3131 | 0.040 |
Why?
|
| Bacteroides | 1 | 2016 | 8 | 0.030 |
Why?
|
| Corynebacterium | 1 | 2015 | 1 | 0.030 |
Why?
|
| Floors and Floorcoverings | 1 | 2015 | 3 | 0.030 |
Why?
|
| Staphylococcus | 1 | 2015 | 9 | 0.030 |
Why?
|
| Lactobacillus | 1 | 2016 | 15 | 0.030 |
Why?
|
| Metagenome | 1 | 2016 | 29 | 0.030 |
Why?
|
| Parturition | 1 | 2015 | 24 | 0.030 |
Why?
|
| New York | 1 | 2015 | 71 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2016 | 40 | 0.030 |
Why?
|
| Dust | 1 | 2015 | 54 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 171 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2015 | 186 | 0.030 |
Why?
|
| Placenta Accreta | 1 | 2014 | 1 | 0.030 |
Why?
|
| Placenta Previa | 1 | 2014 | 2 | 0.030 |
Why?
|
| Postpartum Hemorrhage | 1 | 2014 | 10 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2014 | 27 | 0.030 |
Why?
|
| Parity | 1 | 2014 | 46 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 474 | 0.030 |
Why?
|
| Male | 2 | 2016 | 20025 | 0.030 |
Why?
|
| Uterine Cervical Diseases | 1 | 2013 | 14 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 661 | 0.030 |
Why?
|
| Anus Diseases | 1 | 2013 | 17 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 39 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 885 | 0.030 |
Why?
|
| Length of Stay | 1 | 2014 | 185 | 0.030 |
Why?
|
| Genotype | 1 | 2013 | 730 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 1492 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 1455 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 3562 | 0.020 |
Why?
|